Ken Griffin’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-35
Closed -$1.91K 14965
2023
Q2
$1.91K Buy
+35
New +$2.23K ﹤0.01% 13857
2022
Q3
Sell
-961
Closed -$112K 13433
2022
Q2
$85K Sell
961
-143
-13% -$17.5K ﹤0.01% 11554
2022
Q1
$167K Buy
1,104
+537
+95% +$99.9K ﹤0.01% 11734
2021
Q4
$180K Buy
567
+4
+0.7% +$1.41K ﹤0.01% 12005
2021
Q3
$252K Sell
563
-43,053
-99% -$13.6M ﹤0.01% 11470
2021
Q2
$13M Buy
43,616
+32,044
+277% +$9.54M ﹤0.01% 2672
2021
Q1
$3.45M Buy
11,572
+3,036
+36% +$929K ﹤0.01% 5102
2020
Q4
$2.6M Buy
+8,536
New +$2.51M ﹤0.01% 4821

Other funds holding RBOT

Ken Griffin's RBOT Position: Q3 2023 in Review

Ken Griffin sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 35 shares — an estimated $1.91K sold.

Ken Griffin first reported a position in RBOT in Q4 2020 and held it in 8 quarters. The position peaked at $13M in Q2 2021. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • Ken Griffin reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
  • Ken Griffin sold 35 Vicarious Surgical shares in Q3 2023, an estimated $1.91K.
  • Ken Griffin first reported a position in Vicarious Surgical in Q4 2020 and held it in 8 quarters.
  • Ken Griffin's Vicarious Surgical position peaked at $13M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.